DatasetName,CDC20_S(104) CDC20_S(134) CDC20_S(160) CDC20_S(41) CDC20_S(43) CDC20_S(51) CDC20_S(84) CDC20_S(92) CDC20_T(106) CDC20_T(157) CDC20_T(55) CDC20_T(59) CDC20_T(69) CDC20_T(70) CDC20_T(97),CDC20_T(66)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.47154312400173437,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.5187152090290256,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5083433664184521,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5091935063785002,
RKK2015_TNF-α/basal,0.5293663853494243,
JJ2018_Ratio H/M normalized pP2,0.5017402660506748,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5154250772820078,
HS2024_6_B_T3,0.5323869248371114,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,0.49751106795245004,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5065907241669592,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,0.49167364982957706,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,0.49666869935570823,
HS2024_7_B_N1,0.522526676541013,
FSO2013_Ratio M/L normalized Rep1___1,0.5050754491529507,
SAS2015_AZD/DMSO_Exp3,0.5381390474067114,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5287654267524773,
WZ2023_Pu_010_30min,0.5147210982660669,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5185818373061759,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,0.4731629401661525,
AH2018_TMTMS3_1_C,0.5186562289313038,
JJ2018_Ratio H/L normalized___1,0.5185831379635492,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,0.5124271992586229,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,0.5045690339900122,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.5298273595045709,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,0.506440724712763,
EP2017_Pervanadate R#3 normalized log2 ratio,0.46321092850940465,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,0.5006718868900742,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5142589042810555,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5155242030386551,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.5101680404417728,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5039699635742257,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5075657763210704,
AH2018_SILAC_MR_2_X,0.5196796440613854,
HS2024_4_PD_T2,0.5053101778292844,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5017829050803411,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.4986502520825104,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.4939173585064888,
JJ2018_Ratio M/L normalized pP3,0.4815918578976148,
AH2018_SILAC_M_2_N,0.5288904076364254,
HS2024_7_PD_T2,0.49179930187946136,
FSO2013_Ratio H/L normalized Rep1___1,0.5039692592567824,
AH2018_LFQ_1_C,0.5121722154539522,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,0.47994429856540666,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5211758454609207,
CK2022_11 40-1,0.5049292799144384,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5211647469602954,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5100379169477454,
FSO2013_Ratio H/L normalized Rep2,0.4926205158664203,
WZ2023_Pu_005_20min,0.5158102323036916,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5004281975243391,
CW2012_10 µM Gef/control Experiment 2 Replicate B,0.5129535466141152,
HS2024_7_B_T3,0.4753670505338403,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5400258172340439,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.4869428708883781,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.4850830425575973,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.48699503917167797,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5159992405083975,
CK2022_1 200-1,0.5166754038561764,
PG2020_Intensity Mock_10h_D,0.4805518396781183,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.4773016427183233,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4919168373500367,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,0.5073373224375226,
SAS2015_PLX/AZD_Exp2,0.4986597889685465,
CR2017_Ratio Replicate 3.3,0.5253153167737185,
PG2020_Intensity 2h_C,0.4943199155003603,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5013857246138564,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.47343142634189506,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.4987994717657379,
HS2024_5_PD_T1,0.46680340875585513,
AH2018_LFQ_M_2_C,0.558276951112727,
CK2022_3 40-1,0.5134825522857409,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.4886724312946418,
YA2020_Reporter_intensity_Cancer_No.5,0.510553986869872,
HH2022_Reporter intensity 8,0.5025203408913084,0.6006283084935864
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,0.4928205783554357,
AH2018_TMTMS3_2_N,0.5269628329168144,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.4830526231500768,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5079854845611299,
YA2020_Reporter_intensity_Normal_No.1,0.5017328805797965,
HS2024_3_B_T1,0.5570316572024135,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5163120377119752,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,0.4762512466663293,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.47262051061262406,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5108526664641556,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5138614136234999,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5085927827298301,
KS2014_Intensity N3,,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5043911940289728,
FSO2013_Ratio H/M normalized Rep2,0.4445389088267793,
RAM2015_Log2 A,0.46832249668128006,
HS2024_8_PD_T1,0.4736948325237912,
JJ2018_Ratio H/L normalized pP2,0.5310899207664276,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.5090536479525395,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.47916281125480314,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.5198106988359478,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5005173587447055,
AH2018_SILAC_M_3_X,0.49396815810863653,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.507379198946465,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5291479407256092,
HS2024_6_B_N1,0.5096907157178856,
KBE2022_Log2_Ex_27_T,0.5191606793347304,
CW2012_10 µM Gef/control Experiment 1 Replicate A,0.5043009170881746,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5214166356822051,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,0.47336533153126864,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5007874876762034,0.6499440788705706
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5097948279244335,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.49578748270767287,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5202623417472629,
DL2023_control-1,,
AR2021_ALG 10 μM,0.6086011218802849,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.513804800674262,
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5086391551020852,0.6515971619177984
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5140585267320832,
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.5284212792791675,
AH2018_SILAC_2_N,0.5280386058870961,
CK2022_11 200-1,0.480883578422271,
CK2022_12 200-1,0.48294852191128523,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5018047055925636,0.6082937354733781
WZ2023_Su_010_20min,0.508995602030715,
AH2018_TMTMS2_2_N,0.5016058080844218,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5313955261367925,
KS2014_Intensity N4,0.4836608746668501,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.4950734595305523,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,0.4953125710738145,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5198500504993951,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.4979093847801161,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5120726844918344,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.49455234650372126,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5176473784574707,
CF2017_EOC 1,,
CK2022_3 200-1,0.5148449395342775,
AH2018_LFQ_IT_3_C,0.5330368388662835,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5313201737748764,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.4780814770633473,
HS2024_5_B_T1,0.49931979428687023,
CW2012_10 µM Gef/control Experiment 2 Replicate A,0.5084343823989196,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5380733718810343,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.514003884809155,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5144753094667837,
JW2021_Before_2,,
TM2022_S2.12h.A,0.5044296106079734,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5087834816093474,
AR2021_ALG 1 μM,0.5222796836257807,
HS2024_4_B_T1,0.4925368979190163,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5215758963532261,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,0.5062763138377657,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.4949112514440152,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,0.5122962177511983,
FS2019_db/db3,,
CK2022_15 40-1,0.5101316102179685,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5144424551919667,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5210807868102585,
HS2024_5_PD_T3,0.5424422335576399,
AH2018_TMTMS3_3_X,0.5382186217858895,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.5222155399028325,
KBE2022_Log2_Ex_27_U,0.5220325169584893,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.5343538994605337,
AH2018_SILAC_M_1_N,0.501510048661934,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.5030385019154751,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5020227896945043,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5063690511244043,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5059627663580434,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.4600699753524537,
CW2012_10 µM Erl/control Experiment 2 Replicate B,0.5079825041259841,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.48780066662851307,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.503437906738712,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,
HH2022_Reporter intensity 6,0.5029835003635625,0.6693885298186657
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5057546922656321,
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5004900616303484,
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.5040027304234488,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,0.5038355091928498,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.492820289819872,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5071897997619053,
HS2024_8_B_T2,0.4684031563854059,
AH2018_LFQ_1_X,0.5122797969682257,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5117014417478521,
HH2022_Reporter intensity 1,0.5083410209066588,0.6470044938561995
HH2022_Reporter intensity 2,0.5084588864157541,0.6434252328880531
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5057117721073882,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.4776489852508666,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5261444515639019,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5026122691328393,
CW2012_10 µM Erl/control Experiment 2 Replicate A,0.5272495612699643,
FSO2013_Ratio H/M normalized Rep3,0.48644302050330407,
AR2021_KD 72h,0.5505698729275215,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5182963707189178,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5379149816508912,
KBE2022_Log2_Ex_9_U,0.5142986161015328,
AH2018_SILAC_M_3_N,0.5025875395775541,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.4934920803196556,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.49460676095497413,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5161590759057241,
SAS2015_PLX/AZD_Exp1,0.514560281046908,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.4990842873931928,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.5306940759872146,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5066156455589786,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,0.5043785074526114,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,0.4977299244353833,
PG2020_Intensity 4h_A,0.4996533582189361,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,0.4895528207945825,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.4885933942859652,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.4952367327920252,
CK2022_7 200-1,0.4882954570177909,
CK2022_5 200-1,0.48989762964330336,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.49912844521896094,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5441266655031817,
AH2018_SILAC_MR_1_X,0.5287447237882115,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.49763969563574234,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,0.5162058736969075,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.47470279185410913,
CK2022_4 16-1,0.5157847014762517,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5084087127525121,
SAS2015_PLX/DMSO_Exp1,0.5216555249099558,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,0.5283728674857071,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,0.4982693163978145,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.49196754931865955,
JJ2018_Ratio M/L normalized,0.5109771213727564,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.5095115624965448,
KBE2022_Log2_Ex_9_T,0.5165376391735605,
AH2018_SILAC_IT_2_N,0.49824786743984795,
AH2018_SILAC_IT_1_X,0.5312917659224009,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.48975718587362066,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.5174021606292597,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5268414445855224,
HS2024_4_I_N2,0.5237183514314353,
AH2018_TMTMS2_3_N,0.5042024794485709,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5133784042176692,
WZ2023_Su_005_30min,0.5127412470692266,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5195592137116011,
WZ2023_Su_025_10min,0.5121280758415016,
AH2018_LFQ_IT_4_X,0.49390092244187467,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5111142917711281,
CW2012_10 µM Gef/control Experiment 1 Replicate B,0.5064551460608507,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,0.5072680724152694,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.46347919976029267,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.4971086490598342,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.4688970568054495,
RN2012_L10,,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,0.4836156962044463,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5156357610846557,
HS2024_4_B_T3,0.5159629994024553,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.4908804388598466,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.530956270461784,
HS2024_8_I_T2,0.49555601515076225,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5136137255313499,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.4964879981677435,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.4905910872866805,
GF2025_P9_Sph,,
CK2022_6 200-1,0.4905605173570692,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5434317320885896,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.4946466416212001,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,0.491744416370579,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.4939179786293552,
SAS2015_AZD/DMSO_Exp1,0.5123562059364974,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.5014670972739358,
HS2024_3_B_T3,0.504459412529906,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.4960956716671009,
EP2017_Untreated R#3 normalized log2 ratio,0.47287093257278767,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.48987337951112114,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.4992899117335227,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,0.5038657514223993,
JJ2018_Ratio H/L normalized pP1,0.4802108888306312,
EP2017_Pervanadate R#2 normalized log2 ratio,0.4734257864653965,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5331655730144399,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.4870447062232589,
KBE2022_Log2_Ex_29_T,0.5182347624160352,
HS2024_7_I_T2,0.5002416910730415,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5367583376909087,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,0.49768931003279887,
SAS2015_PLX/DMSO_Exp2,0.539282712748483,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.541457083850381,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.4901976813503207,
ZCP2016_Ratio H/L Rep 1,0.4957656629372137,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.4730953190432537,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.513585317299239,
HS2024_8_PD_T2,0.46750245060586193,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.48103037950435645,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.47184970775023394,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5015441835492778,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,0.5019787825784209,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.48345517463950183,
HS2024_3_PD_T3,0.4948586686778032,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,0.478077815815279,
AH2018_LFQ_M_2_N,0.5302293307950511,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.5159010311356115,
RAM2015_Log2 B,0.4551533706941305,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.521368273878339,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5304678626780365,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,0.49367273004921663,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.5078647440418816,
PG2020_Intensity Mock_10h_B,0.47661394372690563,
WZ2023_Su_025_30min,0.5019035599589614,
AH2018_LFQ_4_N,0.5303514120719349,
CR2017_Ratio Replicate 1.2,0.4998734186473166,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.48771973690979886,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5031231515870936,0.6525395691914327
AH2018_SILAC_M_1_X,0.4629502256742915,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.49078756522130756,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5239599280954023,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5306126029706753,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.4968821048165054,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,0.5065275854561371,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,0.4864310847508305,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5148731924074919,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5347077180750667,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,0.5372246111312785,
PG2020_Intensity 2h_B,0.4709743550128322,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5066011729700054,
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5092154152425259,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5257763737454784,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.4977266947086119,
CR2017_Ratio Replicate 2.4,0.47537054831361386,
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.5139006899269833,
RKK2015_TNF-α/IKKb,0.5362320642188663,
SFR2015_HL_log2_ratio_std_b,0.5115171880550395,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5003583445069405,
CK2022_7 40-1,0.5060624815739413,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5181537743130846,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5014838757889053,
WZ2023_Su_025_20min,0.5073440696276249,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.5004191325462249,
LY2019_P8-,0.5205453605622371,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.4925268348198345,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5095308110096611,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5017819743326908,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.46280186934603157,
FSO2013_Ratio M/L normalized Rep1___3,0.5032160755826257,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5337768378717536,
AH2018_LFQ_M_4_C,0.535757481119966,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.5067990211704527,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5232899909082426,
HS2024_8_PD_T3,0.46841372805028975,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.4752157526957997,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5174732703771795,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.4901435561942422,
FSO2013_Ratio H/M normalized Rep3___3,0.4947356238548334,
AH2018_TMTMS2_2_C,0.5131957384628127,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5322211262587763,
HS2024_8_I_N2,0.48724572105536645,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5102040370095632,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.5017307957935352,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.49294534993528827,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,0.4608504729154351,
JJ2018_Ratio H/L normalized pP3___1,0.5003999131958413,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5237900297569397,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,0.4751075294073212,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5090717150953583,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5137417435629927,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.5293472454167234,
HS2024_6_I_T1,0.48142759297515236,
HS2024_5_B_T3,0.5130891780359041,
JJ2018_Ratio H/M normalized pP1___1,0.47207967809750573,
KBE2022_Log2_Ex_36_U,0.5285737404902113,
AH2018_TMTMS3_3_N,0.5183789046071826,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5395433946087459,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.48185018693679554,
KBE2022_Log2_Ex_36_T,0.524208182840108,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5080475626351109,
KS2014_Intensity C2,0.5006854539882613,
FSO2013_Ratio H/L normalized Rep1___2,0.5079311647614252,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.4817492801660298,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.4798900497964695,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.47043233881049956,
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,0.5213521242631709,
RKK2015_TNF-α/TNF-α+SC-514,0.5244169666457276,
CR2017_Ratio Replicate 2.5,0.4816509082204906,
HS2024_3_I_T3,0.5195051747108209,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5048777325283298,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.46904040737062386,
RKK2015_SC-514/basal,0.5591452133264816,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5172271470080859,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.46540903945089274,
KS2014_Intensity N1,0.5112023540530589,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,0.49418795004092575,
CR2017_Ratio Replicate 1,0.49901466408236195,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5215166567128859,
AH2018_SILAC_MR_2_C,0.5234277208784621,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.49110448611796687,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5431912368705151,
JJ2018_Ratio H/M normalized___1,0.4963687193418556,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.5452489205658535,
HS2024_5_I_N1,0.546288692715868,
HS2024_6_I_N1,0.48910285733969955,
AR2021_KD 48h,0.5607855415493899,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.5178025025448766,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5246862601741497,
KBE2022_Log2_Ex_29_U,0.519880367590401,
HS2024_7_B_T1,0.475344227431379,
AH2018_LFQ_M_2_X,0.5153298640802167,
AH2018_LFQ_IT_4_N,0.5079647023632422,
CK2022_15 200-1,0.49592209459934217,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.4965109612519212,
JJ2018_Ratio M/L normalized pP3___1,0.4813910148702357,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5173049665445995,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5113843292608782,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.4632478588517365,
HS2024_8_B_T3,0.4705693421191404,
YA2020_Reporter_intensity_Cancer_No.3,0.5050538285897918,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.5267939727545543,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5022035449836275,
FSO2013_Ratio H/M normalized Rep3___1,0.4934895699219222,
AH2018_SILAC_M_3_C,0.5135523442734687,
RKK2015_TNF-α+IKKb/TNF-α,0.49759215810683816,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5339007277855411,
AH2018_SILAC_M_2_X,0.5198314422319651,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5127882880505098,
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.4977136015820849,
AH2018_LFQ_M_3_N,0.5073656684793912,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5041632643319327,
CK2022_15 16-1,0.5117577787265728,
CK2022_3 16-1,0.5158867262985375,
LY2019_P4-,0.5009751098619366,
FSO2013_Ratio H/L normalized Rep3___2,0.5078300530032958,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.4763374981681761,
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,0.5057390849703292,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.5405793904325222,
IMM2018_normalised rep. int. CDK5L-1,0.5004233788053144,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4878911590753906,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.5328524236144138,
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5043881267441007,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.49249966008636764,
CK2022_6 16-1,0.5079259600429646,
ZX2022_CB treated Replicate 1,0.5105940294583929,
BS2014_Log2(Ratio H/L normalized Rep_3),0.5206500010777645,
TM2022_mock.12h.C,0.468528823319684,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5088765426296479,0.6456900802587707
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5044547404469516,
AR2021_L41 1 μM,0.4640245633126632,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.4976810408264289,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5077678657737114,
KS2014_Intensity C4,0.49834756564051597,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5165967284955648,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,0.4765466311385854,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.4785237570453779,
SAS2015_PLX/DMSO_Exp3,0.5408237723581106,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.541967003453557,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.5038957902735187,
FSO2013_Ratio H/M normalized Rep2___3,0.453583756693068,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5044252948288672,
WZ2023_Pu_025_10min,0.5105546512586147,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.49613227046403885,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.5333132511764936,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,0.4780392685255709,
WZ2023_Pe_010_30min,0.5209335957202142,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5279331152617509,
KS2014_Intensity C6,0.5073911870526714,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5052140812827656,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5158619277351728,
JJ2018_Ratio H/M normalized pP1,0.47182166002198234,
CK2022_16 40-1,0.5101240362614403,
AH2018_SILAC_IT_2_C,0.45965372342262045,
CK2022_5 40-1,0.5070711097821281,
AH2018_LFQ_3_X,0.5082993804426423,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5007164604749319,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5052748980085102,
VOI2024_0.1uM 2 h_1 mono,0.49808732193743677,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5058235119715498,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.4872588985976191,
PG2020_Intensity CT_B,0.47564933987826297,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5243884652102989,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.529196922826802,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.511775041078847,
YA2020_Reporter_intensity_Cancer_No.4,0.5036556261775096,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,0.4647449450519971,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5110661898958127,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5118242988828439,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.48105432623986955,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.4896109559222579,
AH2018_TMTMS2_1_X,0.49867471739090463,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.5195841833699029,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.4962875837213637,
HH2022_Reporter intensity 4,,0.5894172360192355
RBK2021_1326T Late,,
TM2022_mock.12h.B,0.46753712910842665,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.4947356493091517,
AH2018_SILAC_1_X,0.46079417322804656,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.5341449780393828,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5381765915088964,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.5257663522613831,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.5221530909625384,
SAS2015_PLX/AZD_Exp3,0.519349870210731,
EP2017_Pervanadate R#2 log2 ratio,0.4729424646363006,
AS2011_Ratio H/L Normalized RNAi_2_1,,
